arrow
A

Anna Jansen

University of Antwerp
H指数:55
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CMIP as a novel candidate gene for neurodevelopmental and neuropsychiatric disorders

CMIP作为神经发育和神经精神障碍的新型候选基因

2026-07-010
PRE
Clobazam versus corticosteroid for developmental and epileptic encephalopathy with spike–wave activation in sleep ((D)EE-SWAS): Results of a multicenter observational study

氯巴占与皮质类固醇治疗伴有睡眠棘慢波激活的发育性癫痫性脑病 ((D)EE-SWAS):一项多中心观察性研究的结果

2025-10-240
OAAI
Genetic Landscape of a Cohort of Children With Varicella Zoster Virus Encephalitis, Cerebellitis, and Stroke

水痘-带状疱疹病毒脑炎、小脑炎和卒中患儿的遗传景观

2025-09-010
PRE
mTOR pathway diseases: challenges and opportunities from bench to bedside and the mTOR node

mTOR通路疾病:从实验室到临床的挑战与机遇及mTOR节点

2025-05-270
OA
Vigabatrin-associated brain magnetic resonance imaging abnormalities and clinical symptoms in infants with tuberous sclerosis complex

结节性硬化症婴儿的Vigabatrin相关脑磁共振成像异常和临床症状

2024-12-060
PRE
Ipilimumab plus nivolumab (Ipi plus Nivo) in patients with tumors harboring high tumor mutational burden or load (TMB/TML-H): Results from the Drug Rediscovery Protocol (DRUP)

伊匹木单抗联合纳武利尤单抗(Ipi联合Nivo)在携带高肿瘤突变负荷或突变负荷(TMB/TML-H)的肿瘤患者中的疗效:来自药物再发现方案(DRUP)的结果

2024-09-010
PRE
Prenatal assessment of brain malformations on neuroimaging: an expert panel review
BRAIN
IF11.7
2024-07-260
OAAI
The clinical and genetic spectrum of inherited glycosylphosphatidylinositol deficiency disorders
BRAIN
IF11.7
2024-03-083
OAAI